Skip to main content
SpringerLink
Log in

Gestationsbedingte Trophoblasterkrankungen (Blasenmole und Chorionkarzinom)

  • Chapter
Die Gynäkologie

  • 14k Accesses

Zusammenfassung

Die gestationsbedingten Trophoblasterkrankungen (GTE) umfassen eine zytogenetisch und klinisch heterogene Gruppe von Krankheitsbildern, die durch eine abnorme Proliferation des trophoblastischen Gewebes gekennzeichnet sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Allison KH, Love JE, Garcia RL. (2006) Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast. Arch Pathol Lab Med. 130(12): 1875–1877

    PubMed  Google Scholar 

  • Azab M, Droz JP, Theodore C et al. (1989) Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors. Cancer 64: 1829–1818

    Article  PubMed  CAS  Google Scholar 

  • Bae SN, Kim SJ (1999) Telomerase activity in complete hydatidiform mole. Am J Obstet Gynecol 180 (2): 328–333

    Article  PubMed  CAS  Google Scholar 

  • Baergen RN, Rutgers JL, Young RH, Osann K, Scully RE. (2006) Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol. 100(3): 511–520

    Article  PubMed  Google Scholar 

  • Bagshawe KD (1992) Trophoblastic tumors: diagnostic methods, epidemiology, clinical features and management. In: Coppleson M (ed) Gynecologic oncology. Edinburgh, London, Melbourne, New York, Tokyo: Churchill Livingstone: 1027–1043

    Google Scholar 

  • Bagshawe KD, Dent J, Newlands ES, Begent RHJ, Rustin GJS (1989) The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynecol 96: 795–802

    Article  CAS  Google Scholar 

  • Batorfi J Vegh G, Szepesi J et al. (2004) How long should patients be followed after molar pregnancy? Analysis of serum hCG followup data. Eur J Obstet Gynecol 112: 95–97

    Article  Google Scholar 

  • Cheung AN, Shen DH, Khoo US et al. (1998) p21WAF/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. J Clin Pathol 51 (2): 159–162

    Article  PubMed  CAS  Google Scholar 

  • Chilosi M, Piazzola E, Lestani M et al. (1998) Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 78 (3): 269–276

    PubMed  CAS  Google Scholar 

  • Fulop V, Mok SC, Genest DR et al. (1998) p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 43 (2): 119–127

    PubMed  CAS  Google Scholar 

  • Horowitz NS, Goldstein DP, Berkowitz RS. (2009) Management of gestational trophoblastic neoplasia.Semin Oncol. 2009 Apr;36(2): 181–189

    Google Scholar 

  • Jauniaux E (1999) Partial moles: from postnatal to prenatal diagnosis. Placenta 20 (5–6): 379–388

    Article  PubMed  CAS  Google Scholar 

  • Lavi I, Rao GG, Castrillon DH, Miller DS, Schorge JO (2005) Duration of human chorionic gonadotropin surveillance for parial hydatidiform moles. Am J Obstet Gynecol 192 (5): 1362–1364

    Article  Google Scholar 

  • Lurain JR (2011) Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol. 204(1): 11–18

    Article  PubMed  Google Scholar 

  • Lurain JR. (2010) Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 203(6): 531–539

    Article  PubMed  Google Scholar 

  • Matsui H, Iitsuka Y, Seki K et al. (1998) Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities. Gynecol Obstet Invest 46 (1): 5–8

    Article  PubMed  CAS  Google Scholar 

  • Merchant SH, Amin MB, Viswanatha DS, Malhotra RK, Moehlenkap C, Joste NE (2005) p57kip2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Hum Pathol 36 (2): 180–186

    Article  PubMed  CAS  Google Scholar 

  • Molykutty J, Rajalekshmy TN, Balaraman NM et al. (1998) Proliferating cell nuclear antigen (PCNA) expression in gestational trophoblastic disease (GTD). Neoplasma 45 (5): 301–304

    PubMed  CAS  Google Scholar 

  • Newlands ES, Bagshawe KD, Begent RHJ et al. (1986) Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979–1984). Br J Obstet Gynecol 93: 63–69

    Article  CAS  Google Scholar 

  • Newlands ES, Bower M, Holden L et al. (1998) Management of resistant gestational trophoblastic tumors. J Reprod Med 43 (2): 111– 118

    PubMed  CAS  Google Scholar 

  • Palmer JR, Drscoll SG, Rosenberg L et al. (1999) Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst 91 (7): 635–640

    Article  PubMed  CAS  Google Scholar 

  • Sebire NJ, Seckl MJ. (2010) Immunohistochemical staining for diagnosis and prognostic assessment of hydatidiform moles. Current evidence and future directions. J Reprod Med55: 236–246

    PubMed  Google Scholar 

  • Smith EB, Weed JC, Tyrey L, Hammond CB (1982) Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate-folinic acid. Am J Obstet Gynecol 144: 88–92

    PubMed  CAS  Google Scholar 

  • Soper JT, Evans AC, Clarke-Pearson DL et al (1994) Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide- vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol 83 (1): 113–117

    PubMed  CAS  Google Scholar 

  • Theodore C, Azab M, Droz JP et al. (1989) Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide. Cancer 64: 1824–1828

    Article  PubMed  CAS  Google Scholar 

  • Wang CM, Dixon PH, Decordova S, Hodges MD, Sebire NJ, Ozalp S, Fallahian M, Sensi A, Ashrafi F, Repiska V, Zhao J, Xiang Y, Savage PM, Seckl MJ, Fisher RA. (2009) Identification of 13 novel NLRP7 mutations in 20 families with recurrenthydatidiform mole; missense mutations cluster in the leucine-rich region. J Med Genet. 46(8): 569–575

    Article  PubMed  CAS  Google Scholar 

  • Wong LC, Choo YC, Ma HK (1985) Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 152: 59–62

    PubMed  CAS  Google Scholar 

  • Woolas RP, Bower M, Newlands ES et al. (1998) Influence of chemotherapy for gestational trophoblastic disease on pregnancy outcome. Br J Obstet Gynecol 105 (9): 1032–1035

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsfrauenklinik, Otto-von-Guericke-Universität Magdeburg, Gerhart-Hauptmann-Straße 35, 39108, Magdeburg

    Prof. Dr. med., Dr. h.c. S. D. Costa

Authors
  1. Prof. Dr. med., Dr. h.c. S. D. Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Johann-Wolfgang-Goethe-Universität Frankfurt, Universitätsfrauenklinik, Frankfurt

    Manfred Kaufmann

  2. Otto-von-Guericke-Universität Magdeburg, Universitätsfrauenklinik, Magdeburg

    Serban D. Costa

  3. Friedrich-Alexander-Universität Erlangen-Nürnberg, Klinikum St. Marien, Lehrkrankenhaus der Universität Regensburg, Erlangen-Nürnberg

    Anton Scharl

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Costa, S.D. (2013). Gestationsbedingte Trophoblasterkrankungen (Blasenmole und Chorionkarzinom). In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20923-9_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-20923-9_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-20922-2

  • Online ISBN: 978-3-642-20923-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation